In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm

From January 2020, COVID-19 is spreading around the world producing serious respiratory symptoms in infected patients that in some cases can be complicated by the severe acute respiratory syndrome, sepsis and septic shock, multiorgan failure, including acute kidney injury and cardiac injury. Cost an...

Descripción completa

Detalles Bibliográficos
Autores principales: Artigas, Laura, Coma, Mireia, Matos-Filipe, Pedro, Aguirre-Plans, Joaquim, Farrés, Judith, Valls, Raquel, Fernandez-Fuentes, Narcis, de la Haba-Rodriguez, Juan, Olvera, Alex, Barbera, Jose, Morales, Rafael, Oliva, Baldo, Mas, Jose Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531795/
https://www.ncbi.nlm.nih.gov/pubmed/33006999
http://dx.doi.org/10.1371/journal.pone.0240149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531795/
https://www.ncbi.nlm.nih.gov/pubmed/33006999
http://dx.doi.org/10.1371/journal.pone.0240149

Ejemplares similares